Company
Foamix Pharmaceuticals Ltd. (0001606645)
Standardized SEC financial data for Foamix Pharmaceuticals Ltd. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001606645 · Medicinal Chemicals & Botanical Products.
Gross margin
12.1%
Operating margin
-1000.0%
Net margin
-1000.0%
Revenue growth (YoY)
-33.6%
Return on equity
-541.5%
ROIC
-792.5%
Free cash flow
-$74.5M
Debt / equity
1.86×
Ratios for fiscal year 2017, standardized from SEC filings.
Income statement
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Revenue | $5.5M | $3.7M | — | — |
| Cost of revenue | $59K | $13K | — | — |
Balance sheet
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Cash & equivalents | $31.4M | $16.2M | $28.1M | $44.6M |
| Inventory | — | — | — | $1.4M |
Cash flow
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Operating cash flow | -$27.4M | -$53.2M | -$68.7M | -$73.4M |
| Capital expenditures | $424K | $1.5M | $567K | $1.1M |
Get 0001606645 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001606645/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001606645/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"